| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775281A Osteo proliferation Chinese medicine preparation for external application |
| 05/24/2006 | CN1775257A Chinese medicine for treating bone fracture and preparing method |
| 05/24/2006 | CN1775252A Medicine composition for treating cervical vertebra disease and lumbar vertebra disease, preparing method and use |
| 05/24/2006 | CN1775245A Preparation for resisting osteoproli feration and new preparing method |
| 05/24/2006 | CN1775236A Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method |
| 05/24/2006 | CN1775235A Pseudo-ginseng blood-circulation-invigovating preparation and new preparing method |
| 05/24/2006 | CN1775211A Method and composition for reducing to xicity related to leflunomide treatment |
| 05/24/2006 | CN1256969C Chinese medicine for treating bone disease and its preparation |
| 05/24/2006 | CN1256968C Plaster for treating bone disease |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049433 Providing the fungal biomass; reacting the fungal biomass in an acidic solution, heating to convert chitin in the fungal biomass to glucosamine; separating glucosamine from acidic solution |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049325 Quinoline derivatives as anti-inflammatory agents |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/23/2006 | US7049283 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2301189C Non-steroidal ligands for the estrogen receptor |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006052026A1 Acid salt of benzimidazole derivative and crystal thereof |
| 05/18/2006 | WO2006051997A1 Cystein dioxygenase inducer |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051410A1 Azabenzoxazoles for the treatment of cns disorders |
| 05/18/2006 | WO2006051314A2 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | WO2006050842A1 Dibenzosuberone derivatives |
| 05/18/2006 | WO2006050734A2 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | WO2006050544A2 Tolperison for treating dogs having degenerative spinal symptoms |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006020979A3 Factor vii conjugates for selectively treating neovascularization disorders |
| 05/18/2006 | WO2006015005A3 Use of thyrotropin for regeneration of bone |
| 05/18/2006 | WO2006000224A3 Compositions comprising strontium and vitamin d and uses thereof |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106206 plant extracts is produced from solvent extraction, contains a triglucose-picene structure compounds; as antiinflammatory agents treating autoimmune disease, cosmetic composition for prevent aging, and other skin disorders |
| 05/18/2006 | US20060106115 Osteogenesis promoter containing beta-cryptoxanthin as the active ingredient |
| 05/18/2006 | US20060106087 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106074 Er-b-selective ligands |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105059 Fruit and/or vegetable derived composition |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | DE202006001317U1 Ointment, useful as massaging cream for treating e.g. back pain, comprises e.g. olive oil, bees wax, ginger, Diplotaxis tenuifolia seed, clove seed, cubeb pepper seed, myrtle, true oleander, bitter apple, sulfur, camphor and menthol |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | CA2587173A1 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | CA2586068A1 Dibenzosuberone derivatives |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656949A1 Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 05/17/2006 | EP1656948A1 Osteogenesis promoter |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656374A1 Thiazole derivatives as npy antagonists |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656150A2 Use of bacilli bacteria for the prevention of vertebral compression syndrome in salmonids |
| 05/17/2006 | EP1656130A1 Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/17/2006 | EP1506228A4 Role of p62 in aging-related disease |
| 05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1246810B1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 05/17/2006 | EP1231983B1 Combination of dhea and calcitonin for the treatment of subnormal bone mineral density |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | CN1774448A Growth factor complexes and modulation of cell migration and growth |
| 05/17/2006 | CN1774428A M-stage kinesin inhibitor |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1774257A Method for preparing a centella asiatica extracts rich in madecassoside and in terminoloside |
| 05/17/2006 | CN1774250A (6-(phenoxy)-pyrido[3,4-d) pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis |
| 05/17/2006 | CN1772765A Bionic affinity purifying process of interleukin I natural agonist |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1772250A Haobai prepn for treating wetness impair and its prepn process |
| 05/17/2006 | CN1772230A Medicine Yangrongtongbining |
| 05/17/2006 | CN1772170A Glabrous greenbrier total saponin extract and its prepn and use |
| 05/17/2006 | CN1772148A Bone setting and hourishing capsule and its prepn process |
| 05/17/2006 | CN1772146A Chinese medicine bolus for treating bone injury and its prepn |